0002 000230 27 Dec 2023 | Other | ₩100 Per Share |
0002 000230 28 Dec 2022 | Other | ₩100 Per Share |
0002 000230 29 Dec 2021 | Other | ₩100 Per Share |
0002 000230 29 Dec 2020 | Other | ₩100 Per Share |
0002 000230 27 Dec 2019 | Other | ₩95.24 Per Share |
29 Jul 2025 (49 Days) Date | | - Cons. EPS | - EPS |
7 May 2025 Date | | - Cons. EPS | 6.4K EPS |
6 Feb 2025 Date | | - Cons. EPS | - EPS |
4 Nov 2024 Date | | - Cons. EPS | - EPS |
30 Oct 2024 Date | | - Cons. EPS | - EPS |
0002 000230 27 Dec 2023 | Other | ₩100 Per Share |
0002 000230 28 Dec 2022 | Other | ₩100 Per Share |
0002 000230 29 Dec 2021 | Other | ₩100 Per Share |
0002 000230 29 Dec 2020 | Other | ₩100 Per Share |
0002 000230 27 Dec 2019 | Other | ₩95.24 Per Share |
29 Jul 2025 (49 Days) Date | | - Cons. EPS | - EPS |
7 May 2025 Date | | - Cons. EPS | 6.4K EPS |
6 Feb 2025 Date | | - Cons. EPS | - EPS |
4 Nov 2024 Date | | - Cons. EPS | - EPS |
30 Oct 2024 Date | | - Cons. EPS | - EPS |
Drug Manufacturers - Specialty & Generic Industry | Healthcare Sector | Dae-Chang Park CEO | KRX SM Exchange | KR7000230003 ISIN |
South Korea Country | 72 Employees | - Last Dividend | 5 Mar 2020 Last Split | - IPO Date |
Ildong Holdings Co., Ltd., originally known as Ildong Pharmaceutical Co., Ltd. before its name change in August 2016, stands as a significant player in the pharmaceutical industry both within South Korea and on an international level. Founded in 1941 and headquartered in Seoul, South Korea, the company specializes in the development, manufacture, and supply of pharmaceutical products. Over the years, Ildong Holdings has diversified its offerings to include new drug development focused on combating resistant bacteria, malignant tumors, Alzheimer's disease, obesity, and ageing. Furthermore, the company extends its expertise to the research and production of health foods and ingredients, demonstrating its commitment to enhancing healthcare through innovation.